On 10-12 November 2021 the ReSViNET Foundation will host its 6th conference: “RSVVW'21 - A Global Conference on Novel RSV Preventive and Therapeutic Interventions." The aim of the conference is to learn and to share knowledge on current research and to connect the leading worldwide researchers, scientists, academic scientists, industry researchers, scholars, decision-makers and representatives from the FDA, PATH, WHO, EMA, NIH and BMGF. We endeavor to continue education on RSV and to stimulate discussions regarding the opportunities for future international collaboration and achievements in our field.
FInd all information in our Brochure!
|
COVID-19 Considerations
The planning and organization of RSVVW 2021 will face the unprecedented challenge of the uncertainty caused by the global COVID-19 pandemic. ReSViNET's ways of working and usual activities therefore must be adjusted and adapted to the current environment. Read more about our 2-scenario planning and considerations here.
Organizing committee
|
Deborah Higgins
RSV Vaccine Project at PATH Seattle, Washington, United States Harish Nair Paediatric Infectious Diseases & Global Health, University of Edinburgh Edinburgh, United Kingdom Peter Richmond Faculty of Health & Medical Sciences, Paediatrics, University of Western Australia Perth, Australia Louis Bont ReSViNET Board of Directors, Wilhelmina Children’s Hospital, University Medical Center Utrecht Utrecht, The Netherlands |
|
Leyla Kragten-Tabatabaie
ReSViNET Board of Directors, Julius Clinical Zeist, The Netherlands Sophie Mazur ReSViNET Foundation Zeist, The Netherlands Amber Dassen ReSViNET Foundation Zeist, The Netherlands |
Scientific advisory committee
|
|
Keith Klugman
Pneumonia Program, Bill & Melinda Gates Foundation (BMGF) Seattle, Washington, United States Asuncion Meijas Associate Professor of Pediatrics, Nationwide Children’s Hospital and The Ohio State University Columbus, Ohio, USA Fernando Polack Department of Pediatrics at Vanderbilt University, Director of the INFANT Foundation Buenos Aires, Argentina Yvette Löwensteyn PhD Candidate RSV Research Group, Wilhelmina Children's Hospital Utrecht, The Netherlands Lawrence Mwananyanda Research Assistant Professor, Global Health, Boston University Lusaka, Zambia |
